GO:0098560 cytoplasmic side of late endosome membrane: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098560 describes the cytoplasmic leaflet of the late endosome membrane, including proteins embedded in, attached to, or peripherally associated with it.
• This membrane domain is a hub for cargo sorting, vesicle budding, and signaling events that occur on the cytosolic face of late endosomes.
• Proteins such as LAMP-2, Rab7, and ESCRT components localize to or act at the late endosome membrane, and their dysfunction is linked to disease.
• The cytoplasmic side of the late endosome membrane is critical for endosomal escape of delivered macromolecules and for secretory vesicle transport.
• Experimental dissection of this compartment uses knockout, knock-in, and tagged knock-in cell models combined with imaging and proteomics.
• Understanding GO:0098560 helps interpret membrane trafficking defects in Danon disease, viral egress, and stress-induced organelle remodeling.
Description
The cytoplasmic side of the late endosome membrane (GO:0098560) is defined as the leaflet of the late endosome membrane that faces the cytoplasm, including any protein embedded in, attached to, or peripherally associated with it. This specific membrane domain is where many sorting and signaling events take place because it is accessible to cytosolic machinery such as GTPases, coat proteins, and motor complexes. Late endosomes are dynamic organelles that receive cargo from early endosomes and deliver it to lysosomes or recycle it to the plasma membrane, and the cytoplasmic face is the platform for the molecular decisions that govern these routes. For researchers, GO:0098560 matters because it provides a precise spatial context for interpreting protein localization and function. For example, the GTPase Ypt1p has been implicated at the late Golgi, and related Rab proteins act on late endosome membranes to control tethering and fusion. Similarly, the biophysical requirements for endosomal escape of designed mini-proteins depend on interactions with the cytoplasmic leaflet of endosomal membranes. Thus, annotating proteins to this GO term helps connect molecular function to organelle-level trafficking. This article synthesizes authoritative QuickGO annotation data with published literature to describe the composition, regulation, and experimental models relevant to GO:0098560. It is intended for scientists who need a concise, citation-backed overview of this membrane domain and who may want to design CRISPR-based experiments to study it.
cytoplasmic side of late endosome membrane At A Glance
| GO ID | GO:0098560 |
|---|---|
| GO term | cytoplasmic side of late endosome membrane |
| Ontology | cellular_component |
| Synonym | external leaflet of late endosome membrane; external side of late endosome membrane |
| Major function | Platform for cargo sorting, vesicle budding, and cytosolic signaling on late endosomes |
| Definition | The leaflet of the late endosome membrane that faces the cytoplasm, including any protein embedded in, attached to, or peripherally associated with it. |
| Related cellular component | Late endosome membrane, endosome membrane, lysosomal membrane |
| Associated processes | Endosomal sorting, multivesicular body formation, endosomal escape, secretory vesicle transport |
What Is GO:0098560?
GO:0098560, the cytoplasmic side of late endosome membrane, refers to the outer leaflet of the late endosome membrane that is exposed to the cytosol. It includes integral membrane proteins whose cytoplasmic domains project into the cytosol, peripheral membrane proteins that associate with the lipid bilayer, and proteins that are transiently recruited to this surface. This term is a cellular component annotation that captures a specific subdomain of the late endosome membrane rather than the entire organelle. Synonyms include external leaflet of late endosome membrane and external side of late endosome membrane.
Why Is cytoplasmic side of late endosome membrane Important in Cell Biology?
The cytoplasmic side of the late endosome membrane is important because it is the interface where cytosolic machinery reads and modifies endosomal identity. Defects in proteins that act at this surface can cause cargo mis-sorting, impaired lysosomal delivery, and accumulation of undegraded material, which are hallmarks of lysosomal storage disorders and neurodegenerative conditions. Moreover, this membrane domain is exploited by pathogens and therapeutic carriers: efficient endosomal escape of designed mini-proteins requires specific biophysical properties that govern interaction with the endosomal membrane, and viruses such as Epstein-Barr virus manipulate secretory vesicle transport for virion release. Therefore, studying GO:0098560 provides mechanistic insight into both normal cell biology and disease-associated trafficking defects.
• Serves as the cytosolic platform for ESCRT-mediated sorting and multivesicular body formation.
• Controls endosomal escape of macromolecular therapeutics and designed mini-proteins.
• Is the site of action for Rab GTPases and tethering factors that regulate late endosome fusion.
• Dysfunction of late endosome membrane proteins such as LAMP-2 causes Danon disease, a cardiomyopathy with autophagic vacuolar myopathy.
• Participates in secretory vesicle transport required for mature virion release in herpesviruses.
• Undergoes stress-induced remodeling in budding yeast, linking membrane dynamics to environmental stress.
• Provides a membrane surface for cholesterol trafficking and START domain protein function.
• Is a target for dual environment-responsive polyplex carriers designed for intracellular DNA delivery.
• Helps interpret membrane traffic during late steps of cytokinesis.
• Enables precise annotation of proteins to a specific membrane leaflet for systems-level analyses.
What Happens During cytoplasmic side of late endosome membrane?
Cargo sorting and ESCRT recruitment
In simple terms: Proteins on the outside of the late endosome grab cargo and sort it into small vesicles.
The cytoplasmic face of the late endosome membrane is where ubiquitinated cargo receptors are recognized by ESCRT complexes, leading to inward budding and multivesicular body formation. This process is essential for directing proteins to lysosomes for degradation and is a key step in membrane traffic during late steps of cytokinesis.
Vesicle budding and membrane remodeling
In simple terms: The membrane bends inward to form vesicles that carry cargo.
Membrane deformation at the late endosome requires coordinated action of coat proteins, lipids, and cytosolic factors that assemble on the cytoplasmic leaflet. Stress-induced remodeling of membrane-bound organelles in budding yeast illustrates how this surface can be reorganized under changing conditions.
Endosomal escape of macromolecules
In simple terms: Some therapeutic molecules must cross the late endosome membrane to reach the cytosol.
Designed mini-proteins and polyplex carriers must escape from endosomes into the cytoplasm, and their efficiency depends on biophysical properties that govern interaction with the cytoplasmic side of the endosomal membrane. Dual environment-responsive polyplex carriers have been developed to enhance intracellular delivery of plasmid DNA by exploiting endosomal membrane dynamics.
Secretory vesicle transport and virion release
In simple terms: Late endosome membranes help move vesicles that carry viruses out of the cell.
Epstein-Barr virus BBLF1 mediates secretory vesicle transport to facilitate mature virion release, a process that involves late endosome membrane trafficking. This highlights how the cytoplasmic side of the late endosome membrane participates in specialized secretory events.
Key Genes Involved in GO:0098560 cytoplasmic side of late endosome membrane
The following genes and proteins are experimentally linked to the cytoplasmic side of the late endosome membrane or to processes that occur at this interface.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LAMP2 | Lysosomal-associated membrane protein 2; protects lysosomal membrane and participates in autophagy | Deficiency causes Danon disease; model for late endosome/lysosome membrane dysfunction |
| RAB7A | Late endosomal GTPase controlling fusion and motility | Key regulator of late endosome membrane identity; target for trafficking studies |
| VPS4A | ESCRT-III disassembly ATPase | Required for multivesicular body formation at the late endosome membrane |
| CHMP2A | ESCRT-III component | Involved in membrane scission at the cytoplasmic face of late endosomes |
| TSG101 | ESCRT-I component | Recognizes ubiquitinated cargo on late endosome membrane |
| STAM1 | ESCRT-0 component | Initiates cargo sorting at the late endosome membrane |
| HRS | ESCRT-0 subunit | Binds ubiquitinated receptors on the cytoplasmic side of endosomes |
| YPT1 | Rab GTPase in yeast | Functions at the late Golgi and related membranes; model for Rab-mediated trafficking |
| BBLF1 | Epstein-Barr virus protein | Mediates secretory vesicle transport for virion release |
| NPC1 | Cholesterol trafficking protein | Mutations cause Niemann-Pick type C; related to late endosome membrane cholesterol transport |
| NPC2 | Cholesterol-binding protein | Works with NPC1 in late endosome/lysosome cholesterol egress |
| STARD3 | START domain protein | Transfers cholesterol at late endosome membrane |
| STARD4 | START domain protein | Cytosolic cholesterol carrier interacting with late endosomes |
| VPS36 | ESCRT-II component | Binds ubiquitinated cargo at late endosome membrane |
| SNF7 | ESCRT-III subunit | Forms filaments on the cytoplasmic side of endosomal membranes |
| ALIX | ESCRT accessory protein | Assists ESCRT-III assembly at late endosomes |
| RILP | Rab7 effector | Links late endosomes to dynein for transport |
| ORP1L | Oxysterol-binding protein | Senses cholesterol and regulates late endosome positioning |
How Is cytoplasmic side of late endosome membrane Regulated?
The cytoplasmic side of the late endosome membrane is dynamically regulated by Rab GTPases, particularly Rab7, which cycles between GTP-bound active and GDP-bound inactive states to control effector recruitment. ESCRT assembly is regulated by ubiquitination and deubiquitination of cargo and machinery, and by the AAA-ATPase VPS4. Cholesterol levels in the late endosome membrane influence the recruitment of START domain proteins and oxysterol-binding proteins, thereby affecting membrane trafficking. Stress conditions can induce remodeling of membrane-bound organelles, as shown in budding yeast, indicating that environmental signals modulate this membrane domain.
cytoplasmic side of late endosome membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LAMP2 | Danon disease; autophagic vacuolar myopathy | LAMP2 knockout cardiomyocytes; patient iPSC-derived cardiomyocytes |
| NPC1 | Niemann-Pick type C; cholesterol trafficking | NPC1 knockout HeLa; knock-in of patient mutations |
| NPC2 | Niemann-Pick type C; cholesterol trafficking | NPC2 knockout fibroblasts; overexpression of wild-type vs mutant |
| BBLF1 | Epstein-Barr virus egress | BBLF1 knockout EBV-producing cells; tagged knock-in for imaging |
| RAB7A | Charcot-Marie-Tooth neuropathy; endosomal trafficking | RAB7A knockout or point-mutation knock-in cell lines |
Danon disease and LAMP-2 deficiency
Danon disease is a phenotypic expression of LAMP-2 deficiency, characterized by cardiomyopathy, skeletal myopathy, and intellectual disability. LAMP-2 is a late endosome/lysosome membrane protein, and its loss disrupts autophagic flux and membrane integrity at the cytoplasmic side of these organelles. Experimental models include LAMP2 knockout cells and patient-derived iPSCs.
Viral egress and secretory transport
Epstein-Barr virus BBLF1 mediates secretory vesicle transport to facilitate mature virion release, a process that depends on late endosome membrane trafficking. This links GO:0098560 to viral pathogenesis and suggests that targeting late endosome membrane dynamics could affect virion production.
Cholesterol trafficking disorders
START domain proteins and NPC1/NPC2 regulate cholesterol movement at late endosome membranes. Mutations in NPC1 or NPC2 cause Niemann-Pick type C disease, a neurodegenerative lysosomal storage disorder. The cytoplasmic side of the late endosome membrane is a key site for cholesterol egress and membrane contact formation.
From cytoplasmic side of late endosome membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LAMP2 disrupt late endosome membrane integrity? | LAMP2 knockout cell line (e.g., HeLa or iPSC-derived cardiomyocytes) |
| How does a point mutation in RAB7A affect late endosome positioning? | RAB7A point-mutation knock-in cell line |
| Where does BBLF1 localize during virion release? | BBLF1 tagged knock-in in EBV-producing cells |
| Can overexpression of STARD3 alter cholesterol distribution? | STARD3 overexpression cell model |
| What proteins are recruited to the cytoplasmic side of late endosomes under stress? | Proximity labeling or proteomics in wild-type and knockout backgrounds |
| Does ESCRT-III assembly require VPS4A ATPase activity? | VPS4A knockout or catalytically dead knock-in |
How to Study the cytoplasmic side of late endosome membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fluorescence microscopy | Localization and dynamics of tagged proteins | Visualizing ESCRT recruitment at late endosomes |
| Immunoelectron microscopy | Ultrastructural localization of proteins on membrane leaflets | Confirming cytoplasmic side localization |
| Proximity labeling (BioID/APEX) | Proteins in close proximity to a bait on late endosomes | Mapping the cytoplasmic interactome |
| Subcellular fractionation + mass spectrometry | Protein composition of late endosome fractions | Identifying novel components |
| Endosomal escape reporter assay | Cytosolic delivery of macromolecules | Testing designed mini-proteins |
| CRISPR knockout screen | Genes required for cargo sorting or membrane integrity | Unbiased discovery of trafficking regulators |
| Cholesterol trafficking assay | Distribution of cholesterol between membranes | Studying NPC1/NPC2 and START domain proteins |
| Viral egress assay | Release of mature virions | Evaluating BBLF1 function |
Imaging of late endosome membrane dynamics
Fluorescence microscopy with tagged late endosome markers (e.g., GFP-Rab7, LAMP1-GFP) allows visualization of membrane remodeling and cargo sorting at the cytoplasmic side. Live-cell imaging can capture ESCRT recruitment and vesicle budding events.
Proteomics of isolated late endosomes
Biochemical fractionation followed by mass spectrometry can identify proteins enriched on the cytoplasmic face of late endosomes. Comparative proteomics between wild-type and knockout cells reveals candidates regulated by specific genes.
Endosomal escape assays
Designed mini-proteins or polyplex carriers can be tested for endosomal escape efficiency using reporter assays. Biophysical parameters such as membrane affinity and pH responsiveness are measured to correlate with escape.
Genetic screens for trafficking defects
CRISPR knockout libraries coupled with fluorescent cargo reporters enable unbiased identification of genes required for late endosome membrane function. Hits can be validated by imaging and biochemical assays.
How CRISPR Can Be Used to Study GO:0098560 cytoplasmic side of late endosome membrane
Knockout
CRISPR knockout of genes such as LAMP2, RAB7A, or ESCRT components can abolish protein function and reveal their roles at the cytoplasmic side of the late endosome membrane. Knockout cell lines are useful for loss-of-function studies in trafficking and disease modeling.
Point Mutation
Introducing disease-associated point mutations (e.g., in NPC1 or RAB7A) via CRISPR base editing or homology-directed repair allows precise modeling of altered protein function at the late endosome membrane. These models help distinguish loss-of-function from gain-of-function effects.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) into endogenous loci enables real-time imaging of proteins at the cytoplasmic side of late endosomes. Tagged knock-in lines preserve native regulation and are ideal for live-cell dynamics studies.
Overexpression
CRISPR activation or lentiviral overexpression of genes such as STARD3 or BBLF1 can amplify specific functions at the late endosome membrane. Overexpression models are useful for gain-of-function screens and for testing therapeutic candidates.
How EDITGENE Supports cytoplasmic side of late endosome membrane Research
Researchers studying cytoplasmic side of late endosome membrane-related genes often need to determine whether a candidate gene is causally involved in membrane trafficking, cargo sorting, or disease-associated dysfunction. EDITGENE provides validated CRISPR tools and services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for cytoplasmic side of late endosome membrane research.
Frequently Asked Questions About cytoplasmic side of late endosome membrane
What is GO:0098560?
GO:0098560 is the Gene Ontology term for the cytoplasmic side of the late endosome membrane, the leaflet of the late endosome membrane that faces the cytoplasm and includes associated proteins.
What genes are involved in the cytoplasmic side of the late endosome membrane?
Key genes include LAMP2, RAB7A, ESCRT components (VPS4A, CHMP2A, TSG101), and cholesterol trafficking proteins such as NPC1 and STARD3.
What is the function of the late endosome membrane?
The late endosome membrane serves as a platform for cargo sorting, multivesicular body formation, and fusion with lysosomes, with the cytoplasmic side coordinating these events.
How is the cytoplasmic side of the late endosome membrane studied?
It is studied using fluorescence microscopy, proteomics, endosomal escape assays, and CRISPR knockout screens.
What diseases are linked to late endosome membrane proteins?
Danon disease (LAMP2), Niemann-Pick type C (NPC1/NPC2), and Charcot-Marie-Tooth neuropathy (RAB7A) are linked to late endosome membrane dysfunction.
What is the role of LAMP2 in the late endosome membrane?
LAMP2 is a lysosomal/late endosome membrane protein that protects the membrane and is deficient in Danon disease.
How do ESCRT proteins function at the late endosome membrane?
ESCRT complexes recognize ubiquitinated cargo on the cytoplasmic side and mediate inward budding to form multivesicular bodies.
Can CRISPR be used to study late endosome membrane genes?
Yes, CRISPR knockout, knock-in, and overexpression models enable precise functional studies of genes at the late endosome membrane.
What is endosomal escape and how does it relate to GO:0098560?
Endosomal escape is the process by which macromolecules cross the late endosome membrane into the cytosol, often involving the cytoplasmic leaflet.
What model systems are used for late endosome membrane research?
Common models include HeLa cells, iPSC-derived cardiomyocytes, budding yeast, and EBV-producing cells, often engineered with CRISPR.
Conclusion
GO:0098560, the cytoplasmic side of the late endosome membrane, is a functionally critical membrane domain that coordinates cargo sorting, vesicle budding, and signaling. Its components are implicated in diseases ranging from Danon disease to cholesterol trafficking disorders, and it is a target for therapeutic delivery and viral egress. By combining QuickGO annotations with CRISPR-based experimental models, researchers can dissect the molecular mechanisms operating at this interface. EDITGENE offers comprehensive services to accelerate such studies, from knockout and knock-in cell lines to library screening and bioinformatics.
References
- 1. Frémont S et al.. 2018. Membrane Traffic in the Late Steps of Cytokinesis.. Curr Biol 28(8):R458-R470 PMID: 29689230
- 2. Sanjoh M et al.. 2012. Dual environment-responsive polyplex carriers for enhanced intracellular delivery of plasmid DNA.. Biomacromolecules 13(11):3641-9 PMID: 22994314
- 3. Giudice J et al.. 2025. The biophysical requirements that govern the efficient endosomal escape of designed mini-proteins.. Nat Chem 17(8):1227-1235 PMID: 40629095
- 4. Endo Y et al.. 2015. Danon disease: a phenotypic expression of LAMP-2 deficiency.. Acta Neuropathol 129(3):391-8 PMID: 25589223
- 5. Sheng P et al.. 2026. Stress-induced remodeling of membrane-bound organelles in budding yeast.. Curr Res Microb Sci 11:100653 PMID: 42598231
- 6. Uddin MK et al.. 2023. Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release.. J Virol 97(6):e0043723 PMID: 37195206
- 7. Strauss JF 3rd et al.. 2003. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells.. Mol Cell Endocrinol 202(1-2):59-65 PMID: 12770731
- 8. Sclafani A et al.. 2010. Establishing a role for the GTPase Ypt1p at the late Golgi.. Traffic 11(4):520-32 PMID: 20059749
